The Head and the Foot Inhibitor from Hydra Are Not Dowex Artefacts

Overview

Journal Wilehm Roux Arch Dev Biol

Specialty Anatomy & Histology

Date 2017 Mar 18

PMID 28305595

Citations 1

Authors

H Chica Schaller

Affiliations

Soon will be listed here.

Abstract

In a recent publication in this journal (Berking 1983) it was claimed (1) that the head inhibitor we isolated from hydra is a Dowex artefact, (2) that a separate foot inhibitor does not exist in hydra and (3) that the only inhibitor that has so far been isolated from hydra is one which inhibits head and foot regeneration equally well. These statements are incorrect and require a response. In the following, I would like to summarise our evidence that the inhibitors isolated from hydra, including Berking's inhibitor, have different specificities for head and foot regeneration. In addition, I would like to show that none of our substances are Dowex artefacts.

Citing Articles

Hydra pattern is controlled by two distinct but interacting morphogen sets.

Sinha S, Mookerjee S Wilehm Roux Arch Dev Biol. 2017; 194(1):56-60.

PMID: 28305195 DOI: 10.1007/BF00848956.

References

MacWilliams H, Kafatos F . Hydra viridis: inhibition by the basal disk of basal disk differentiation. Science. 1968; 159(3820):1246-7. DOI: 10.1126/science.159.3820.1246. View

Schaller H . Head regeneration inHydra is initiated release of head activator and inhibitor. Wilehm Roux Arch Dev Biol. 2017; 180(4):287-295. DOI: 10.1007/BF00848775. View

Schmidt T, Schaller H . Properties of the foot inhibitor from hydra. Wilehm Roux Arch Dev Biol. 2017; 188(2):133-139. DOI: 10.1007/BF00848805. View

MacWilliams H . Hydra transplantation phenomena and the mechanism of Hydra head regeneration. II. Properties of the head activation. Dev Biol. 1983; 96(1):239-57. DOI: 10.1016/0012-1606(83)90325-1. View

Berking S, Gierer A . Analysis of early stages of budding inHydra by means of an endogenous inhibitor. Wilehm Roux Arch Dev Biol. 2017; 182(2):117-129. DOI: 10.1007/BF00848052. View

Berking S . Bud formation inHydra: Inhibition by an endogenous morphogen. Wilehm Roux Arch Dev Biol. 2017; 181(3):215-225. DOI: 10.1007/BF00848422. View

Berking S . The fractionation of aHydra-derived inhibitor into head and foot inhibitors may be an artefact. Wilehm Roux Arch Dev Biol. 2017; 192(6):327-332. DOI: 10.1007/BF00848812. View

Berking S . Analysis of head and foot formation inHydra by means of an endogenous inhibitor. Wilehm Roux Arch Dev Biol. 2017; 186(3):189-210. DOI: 10.1007/BF00848589. View

Schmidt T, Schaller H . Evidence for a foot-inhibiting substance in hydra. Cell Differ. 1976; 5(3):151-9. DOI: 10.1016/0045-6039(76)90017-8. View

10.

Schaller H, Schmidt T, Grimmelikhuijzen C . Separation and specificity of action of four morphogens from hydra. Wilehm Roux Arch Dev Biol. 2017; 186(2):139-149. DOI: 10.1007/BF00848175. View

11.

MacWilliams H . Hydra transplantation phenomena and the mechanism of hydra head regeneration. I. Properties of the head inhibition. Dev Biol. 1983; 96(1):217-38. DOI: 10.1016/0012-1606(83)90324-x. View

12.

Schaller H, Schmidt T, Flick K, Grimmelikhuijzen C . Analysis of morphogenetic mutants of hydra : I. TheAberrant. Wilehm Roux Arch Dev Biol. 2017; 183(3):193-206. DOI: 10.1007/BF00867320. View

13.

Berking S . Control of nerve cell formation from multipotent stem cells in Hydra. J Cell Sci. 1979; 40:193-205. DOI: 10.1242/jcs.40.1.193. View